A vascular graft is a medical device that acts as an artificial blood vessel. It is implanted in patients with blocked blood vessels to redirect the flow of blood from one organ to the other to restore the normal flow of blood within the body.
The global vascular graft market is driven by increase in the incidence of vascular disorders, high blood glucose level, hypertension, and other risk factors that cause blockage of blood vessels. The global vascular grafts market was valued at $4,192 million in 2016, and is expected to reach at $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. In addition, sedentary lifestyle, rise in geriatric population, and technological advancements supplement the market growth. However, high cost of treatment and increase in complications associated with prosthetic grafts restrain the market growth. Conversely, rise in awareness for vascular grafts and huge market opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities to the market players in the near future.
The global vascular graft market is segmented on the basis of product, raw material, end user, and region. On the basis of product, it is classified into endovascular stent graft, peripheral vascular graft, and hemodialysis access graft. The endovascular stent graft segment is bifurcated into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of raw material, it is categorized into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. Based on end user, it is divided into hospitals & ambulatory surgical centers. The market is analyzed based on region into North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Comprehensive analyses of the product type and raw materials help in understanding the regional trends and potential investment areas.
Key market players and their strategies have been thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Product
Hemodialysis Access Graft
Endovascular Aneurysm Repair Stent Grafts
Abdominal Aortic Aneurysm (AAA)
Thoracic Aortic Aneurysm (TAA)
Peripheral Vascular Graft
By Raw Material
Polytetrafluoroethylene (PTFE)
Polyurethane (PU)
Polyester
Biosynthetic
By End User
Hospitals
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
List of key players profiled in the report
B. Braun Melsungen AG
C. R. Bard Inc.
Cardinal Health Inc.
Cook Medical Inc.
Endologix Inc.
LeMaitre Vascular Inc.
MAQUET Holding B.V. & Co. KG (a Getinge Group Company)
Medtronic plc.
Terumo Corporation
W. L. Gore & Associates Inc.
List of the other players in the value chain (these players are not profiled in the report, the same can be included on request)
Cardiatis SA
JOTEC GmbH
Lombard Medical Inc.
Japan Lifeline Co. Ltd.
Nano Endoluminal
